HCA Healthcare Inc (HCA):企業の財務・戦略的SWOT分析

◆英語タイトル:HCA Healthcare Inc (HCA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH29920FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:71
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

HCA Healthcare Inc (HCA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

HCA Healthcare Inc (HCA) is a health care services company that provides a wide range of services in specialties including general surgery, internal medicine, cardiology, oncology, neurosurgery, orthopaedics and obstetrics. It also offers outpatient and ancillary health care services, diagnostic and emergency services and mental health care services. The company operates a network of hospitals; freestanding surgery and endoscopy centers and emergency care facilities; diagnostic and imaging centers; radiation and oncology therapy centers; comprehensive rehabilitation and physical therapy centers; and various other facilities. It operates facilities in the US and the UK. HCA is headquartered in Nashville, Tennessee, the US.

HCA Healthcare Inc Key Recent Developments

Mar 31,2021: HCA Healthcare, Inc. 1st Quarter 2021 Earnings Conference Call
Feb 25,2021: Brookdale to divest 80% stake in Brookdale Health Care Services for $400m
Feb 23,2021: HCA Healthcare named a 2021 World’s Most Ethical Company
Feb 18,2021: HCA Healthcare, Inc. to Present at February and March Healthcare Conferences
Feb 02,2021: HCA Healthcare reports fourth quarter 2020 results and provides 2021 guidance

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
HCA Healthcare Inc – Key Facts
HCA Healthcare Inc – Key Employees
HCA Healthcare Inc – Key Employee Biographies
HCA Healthcare Inc – Major Products and Services
HCA Healthcare Inc – History
HCA Healthcare Inc – Company Statement
HCA Healthcare Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
HCA Healthcare Inc – Business Description
Product Category: Managed Care and Other Insurers
Performance
Product Category: Managed Medicaid
Performance
Product Category: Managed Medicare
Performance
Product Category: Medicaid
Performance
Product Category: Medicare
Performance
Product Category: Other
Performance
Geographical Segment: American Group
Target Markets
Performance
Key Stats
Geographical Segment: Corporate and Other Group
Target Markets
Performance
Key Stats
Geographical Segment: National Group
Target Markets
Performance
Key Stats
HCA Healthcare Inc – Corporate Strategy
HCA Healthcare Inc – SWOT Analysis
SWOT Analysis – Overview
HCA Healthcare Inc – Strengths
HCA Healthcare Inc – Weaknesses
HCA Healthcare Inc – Opportunities
HCA Healthcare Inc – Threats
HCA Healthcare Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
HCA Healthcare Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 31, 2021: HCA Healthcare, Inc. 1st Quarter 2021 Earnings Conference Call
Feb 25, 2021: Brookdale to divest 80% stake in Brookdale Health Care Services for $400m
Feb 23, 2021: HCA Healthcare named a 2021 World’s Most Ethical Company
Feb 18, 2021: HCA Healthcare, Inc. to Present at February and March Healthcare Conferences
Feb 02, 2021: HCA Healthcare reports fourth quarter 2020 results and provides 2021 guidance
Jan 26, 2021: HCA Healthcare uses its COVID-19 registry by forming consortium with AHRQ and research institutions to accelerate COVID-19 research
Jan 21, 2021: HCA Healthcare invests in domestic production of PPE
Jan 14, 2021: HCA Healthcare 4th quarter 2020 earnings conference call
Dec 07, 2020: Mitch Edgeworth appointed President of HCA Healthcare’s TriStar Division
Oct 26, 2020: HCA Healthcare reports third quarter 2020 results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
HCA Healthcare Inc, Key Facts
HCA Healthcare Inc, Key Employees
HCA Healthcare Inc, Key Employee Biographies
HCA Healthcare Inc, Major Products and Services
HCA Healthcare Inc, History
HCA Healthcare Inc, Other Locations
HCA Healthcare Inc, Subsidiaries
HCA Healthcare Inc, Joint Venture
HCA Healthcare Inc, Key Competitors
HCA Healthcare Inc, Ratios based on current share price
HCA Healthcare Inc, Annual Ratios
HCA Healthcare Inc, Annual Ratios (Cont...1)
HCA Healthcare Inc, Annual Ratios (Cont...2)
HCA Healthcare Inc, Interim Ratios
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
HCA Healthcare Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[HCA Healthcare Inc (HCA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Merus NV (MRUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Merus NV (Merus) is a clinical-stage immuno-oncology company that discovers and develops human bispecific antibody therapeutics for the treatment of cancer. The company’s pipeline antibody candidates are intended for the treatment of breast cancer, ovarian cancer, colorectal cancer, acute my …
  • Ranpak Holdings Corp (PACK):企業の財務・戦略的SWOT分析
    Ranpak Holdings Corp (PACK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • KBI Biopharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary KBI Biopharma Inc (KBI) a subsidiary of JSR Corp is a biopharmaceutical contract development and manufacturing organization that develops novel discoveries into life changing biological products. The organization’s service portfolio includes process development and cGMP manufacturing of reco …
  • Endocyte Inc (ECYT):企業の財務・戦略的SWOT分析
    Summary Endocyte Inc (Endocyte) is a biopharmaceutical company that develops targeted therapies for the treatment of cancer and inflammatory diseases. The company’s pipeline products include Lu-PSMA-617 and Ac-PSMA-617 for radiologand therapy, and FITC CAR-T. Endocyte's proprietary small molecule dr …
  • Relay Medical Corp (CHX):企業の財務・戦略的SWOT分析
    Summary Relay Medical Corp(Relay), formerly Chromedx Corp, is a medical technology company that develops medical devices for in vitro diagnostics and point-of-care testing. The company offers technologies based on granted and pending patents such as HemoPalm and AUF. Its HemoPalm provides a combinat …
  • Nice-Pak Products, Inc.:企業の戦略・SWOT・財務情報
    Nice-Pak Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nice-Pak Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Kalle GmbH:企業の戦略的SWOT分析
    Kalle GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • RespireRx Pharmaceuticals Inc (RSPI):企業の財務・戦略的SWOT分析
    RespireRx Pharmaceuticals Inc (RSPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Invenergy LLC:電力:M&Aディール及び事業提携情報
    Summary Invenergy LLC (Invenergy) is a full-service energy solutions provider. It invests, develops, constructs, owns, and operates renewable and other clean energy generation and storage facilities. The company captures, generates, and stores power from wind, solar, natural gas, and energy storage …
  • Tektronix, Inc.:企業の戦略・SWOT・財務分析
    Tektronix, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tektronix, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Cape plc:企業の戦略・SWOT・財務情報
    Cape plc - Strategy, SWOT and Corporate Finance Report Summary Cape plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Graham Packaging Company, L.P.:企業の戦略・SWOT・財務情報
    Graham Packaging Company, L.P. - Strategy, SWOT and Corporate Finance Report Summary Graham Packaging Company, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • European Institute of Oncology:製薬・医療:M&Aディール及び事業提携情報
    Summary European Institute of Oncology (IEO) is a research institute that conducts clinical and scientific research on cancer prevention, early diagnosis and treatment of cancer. The institute offers medical care services for breast tumors, lung tumors, cervical tumors, endometrial tumors, thoracic …
  • InnoMedica Holding AG:製薬・医療:M&Aディール及び事業提携情報
    Summary InnoMedica Holding AG (InnoMedica) discovers and develops therapeutics for the treatment of cancer. The company develops drugs using its proprietary drug delivery technology, Talidox, based on the transport and release of active pharmaceutical agents, locally, at the target area. Its pipelin …
  • Tennessee Valley Authority-エネルギー分野:企業M&A・提携分析
    Summary Tennessee Valley Authority (TVA) is a corporate agency providing electricity for business customers, local power companies and distributors. The agency generates power using diverse sources of energy such as hydro, nuclear, coal, diesel generator and other renewable based power plants. TVA p …
  • Innate Immunotherapeutics Ltd (IIL):製薬・医療:M&Aディール及び事業提携情報
    Summary Innate Immunotherapeutics Ltd (Innate Immunotherapeutics), formerly Innate Therapeutics Ltd is a pharmaceutical company that develops therapeutic drugs for the treatment of cancer and infectious diseases. The company utilizes immunomodulator microparticle technology. It develops lead drug ca …
  • ABM Industries Incorporated:企業の戦略・SWOT・財務分析
    ABM Industries Incorporated - Strategy, SWOT and Corporate Finance Report Summary ABM Industries Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Deutsche Bank AG (DBK):企業の財務・戦略的SWOT分析
    Deutsche Bank AG (DBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Complix NV:製薬・医療:M&Aディール及び事業提携情報
    Summary Complix NV (Complix) is a biopharmaceutical company that discovers and develops alphabodies and pre-clinical programs. The company’s products comprise CMPX-1023, a novel alphabody for autoimmune diseases, and cell penetrating alphabodies for the treatment of cancer, among others. It designs …
  • Murata Manufacturing Co Ltd (6981):企業の財務・戦略的SWOT分析
    Murata Manufacturing Co Ltd (6981) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆